These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30946384)

  • 1. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
    Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
    Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].
    Jaumouillé S; Espargillière D; Mouriaux F; Mortemousque B
    J Fr Ophtalmol; 2015 May; 38(5):377-87. PubMed ID: 25913441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
    Eo DR; Lee MG; Ham DI; Kang SW; Lee J; Cha HS; Koh E; Kim SJ
    J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
    Tsang A; Kanda P; Gottlieb C; Virgili G; Kantungane L; Coupland S
    Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERCI: a machine learning approach to identifying hydroxychloroquine retinopathy using mfERG.
    Habib F; Huang H; Gupta A; Wright T
    Doc Ophthalmol; 2022 Aug; 145(1):53-63. PubMed ID: 35732856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
    Forte R; Haulani H; Dyrda A; Jürgens I
    Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
    Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
    Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.